Diagnostic options · UAE

Genetic tests in Dubai & UAE

Compare available Genetic tests, their listed prices and the information provided for each option. Test selection and preparation should be discussed with your clinician.

Tests in this category

805

Listed price range

600.00–30,000.00 AED

Clinical preparation

Confirm test-specific instructions with your clinician or laboratory.

Compare available tests

Genetic test prices

Showing 16–30 of 805 matching tests.

Genetic diagnostic tests, details, and listed prices
Test and description	Specimen	Typical duration	Price	Options
TEST-4735 ACAD9 Gene Leigh Syndrome and Mitochondrial Encephalopathy Genetic Test This test identifies pathogenic variants in the ACAD9 gene associated with Leigh syndrome and mitochondrial encephalopathy.	Peripheral whole blood (EDTA)	3 – 4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["ACAD9 gene sequence", "Copy Number Variations (CNVs) in ACAD9"] Parameters [] Preparation ["Provide a detailed three-generation family pedigree", "Complete clinical history during pre-test genetic counselling"] Indications ["Clinical suspicion of Leigh syndrome", "Clinical suspicion of mitochondrial encephalopathy", "Family history of mitochondrial disorders"] Measurement technique Confirm with laboratory Codes LOINC: 81315-5 ICD-10: G31.82, E88.49 Clinical summary This test identifies pathogenic variants in the ACAD9 gene associated with Leigh syndrome and mitochondrial encephalopathy.
TEST-6130 ACADL Gene LCAD Deficiency Genetic Test This test analyzes the ACADL gene for pathogenic variants associated with Long-Chain Acyl-CoA Dehydrogenase (LCAD) deficiency, an inherited metabolic disorder.	Peripheral Whole Blood (EDTA) or Dried Blood Spot (DBS)	3–4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the ACADL gene", "Single Nucleotide Variants (SNVs)", "Insertions/Deletions (Indels)", "Copy Number Variations (CNVs)"] Parameters [] Preparation ["No specific fasting required for blood sample.", "Inform lab of any medications or dietary modifications."] Indications ["Clinical suspicion of LCAD deficiency", "Carrier testing", "Family screening", "Guiding dietary management"] Measurement technique Confirm with laboratory Codes LOINC: 21661-2 ICD-10: E71.39 Clinical summary This test analyzes the ACADL gene for pathogenic variants associated with Long-Chain Acyl-CoA Dehydrogenase (LCAD) deficiency, an inherited metabolic disorder.
TEST-5955 ACADM Gene (Medium-Chain Acyl-CoA Dehydrogenase Deficiency) Genetic Test This genetic test identifies pathogenic variants in the ACADM gene associated with Medium-Chain Acyl-CoA Dehydrogenase Deficiency (MCAD deficiency).	Peripheral Whole Blood (EDTA tube)	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["ACADM gene sequence", "Pathogenic variants"] Parameters [] Preparation ["No fasting required", "Provide complete family history", "Provide previous metabolic test results"] Indications ["Newborn screening abnormalities", "Unexplained hypoglycemia", "Family history of MCAD deficiency", "Sudden infant death"] Measurement technique Confirm with laboratory Codes LOINC: 82232-2 ICD-10: E71.31 Clinical summary This genetic test identifies pathogenic variants in the ACADM gene associated with Medium-Chain Acyl-CoA Dehydrogenase Deficiency (MCAD deficiency).
TEST-5911 ACADSB Gene 2‑Methylbutyrylglycinuria Genetic Test This genetic test evaluates the ACADSB gene for pathogenic variants associated with 2‑methylbutyrylglycinuria.	Peripheral Whole Blood (EDTA) or Saliva (Oragene)	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["ACADSB gene sequence", "Copy Number Variations (CNV) in ACADSB"] Parameters [] Preparation ["Do not discontinue prescribed medication", "Do not alter dietary supplements or metabolic formulas without physician consultation"] Indications ["Clinical suspicion of 2‑methylbutyrylglycinuria", "Carrier screening", "Family planning"] Measurement technique Confirm with laboratory Codes LOINC: 55230-4 ICD-10: E71.11 Clinical summary This genetic test evaluates the ACADSB gene for pathogenic variants associated with 2‑methylbutyrylglycinuria.
TEST-5946 ACHE Gene Acetylcholinesterase Deficiency Genetic Test This test identifies pathogenic variants in the ACHE gene associated with acetylcholinesterase deficiency.	Peripheral whole blood (5 mL EDTA)	3 to 4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the ACHE gene", "Single-nucleotide variants", "Small insertions/deletions"] Parameters [] Preparation ["No fasting is required", "Inform phlebotomist if taking anticoagulants", "Avoid blood-thinning medications for 24 hours before the draw unless otherwise advised by your doctor"] Indications ["Individuals with a family history of abnormal anaesthesia reactions", "Individuals with unexplained post-operative respiratory failure", "Pre-anaesthetic risk assessment"] Measurement technique Confirm with laboratory Codes LOINC: 77607-5 ICD-10: E85.8, Z13.71 Clinical summary This test identifies pathogenic variants in the ACHE gene associated with acetylcholinesterase deficiency.
TEST-3707 ACOX1 Gene (Peroxisomal Acyl-CoA Oxidase Deficiency) Genetic Test This test evaluates the ACOX1 gene for pathogenic variants associated with peroxisomal acyl-CoA oxidase deficiency.	Peripheral Whole Blood	21-28 Working Days	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the ACOX1 gene", "Single-nucleotide variants", "Small indels", "Copy-number changes"] Parameters [] Preparation ["No specific fasting required", "Do not discontinue anti-epileptic medications or specialized dietary formulas without consultant direction"] Indications ["Suspected peroxisomal acyl-CoA oxidase deficiency", "Severe neurological impairment in infancy"] Measurement technique Confirm with laboratory Codes LOINC: 94541-6 ICD-10: E71.510 Clinical summary This test evaluates the ACOX1 gene for pathogenic variants associated with peroxisomal acyl-CoA oxidase deficiency.
TEST-6105 ACP2 Gene Lysosomal Acid Phosphatase Deficiency Genetic Test This genetic test evaluates the ACP2 gene for mutations associated with lysosomal acid phosphatase deficiency.	Whole blood	3–4 weeks from sample receipt	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["ACP2 gene mutations", "Point mutations", "Small indels", "Copy-number variations"] Parameters [] Preparation ["Ensure adequate hydration", "Discontinue anticoagulants only under physician guidance", "Pre-test genetic counseling is mandatory"] Indications ["Suspected lysosomal acid phosphatase deficiency", "Family history of the disorder", "Carrier screening in at-risk families"] Measurement technique Confirm with laboratory Codes LOINC: 92851-1 ICD-10: E77.8 Clinical summary This genetic test evaluates the ACP2 gene for mutations associated with lysosomal acid phosphatase deficiency.
TEST-5294 ACTA1 Gene Nemaline Myopathy Type 3 Genetic Test This test evaluates the ACTA1 gene for pathogenic variants associated with nemaline myopathy type 3.	Peripheral Venous Blood (EDTA)	3 to 4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the ACTA1 gene"] Parameters [] Preparation ["Pre-test genetic counselling session required", "Informed consent required"] Indications ["Unexplained muscle weakness", "Hypotonia", "Family history of congenital myopathies", "Suspected nemaline myopathy type 3"] Measurement technique Confirm with laboratory Codes LOINC: 88554-0 ICD-10: G71.2 Clinical summary This test evaluates the ACTA1 gene for pathogenic variants associated with nemaline myopathy type 3.
TEST-4138 ACTA2 Gene Moyamoya Disease Type 5 Genetic Test This test identifies genetic variants within the ACTA2 gene associated with Moyamoya disease type 5.	Peripheral whole blood	3–4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Single-nucleotide variants in ACTA2 gene", "Small insertions and deletions in ACTA2 gene", "Copy number changes in ACTA2 gene"] Parameters [] Preparation ["Mandatory pre-test genetic counselling session required", "No fasting required", "No medication adjustments needed before blood draw"] Indications ["Symptomatic individuals suspected of Moyamoya disease type 5", "Individuals with a positive family history of ACTA2-related disease", "Presymptomatic family members of affected individuals", "Confirmation of clinical diagnosis"] Measurement technique Confirm with laboratory Codes LOINC: 81765-6 ICD-10: I67.5, Q28.8, Z15.89 Clinical summary This test identifies genetic variants within the ACTA2 gene associated with Moyamoya disease type 5.
TEST-3079 ACTB Gene Baraitser-Winter Syndrome Type 1 Genetic Test This genetic test identifies pathogenic variants within the ACTB gene, confirming a diagnosis of Baraitser-Winter syndrome type 1.	Blood (EDTA) or DNA FTA Card	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the ACTB gene", "Coding exons and flanking intronic regions of ACTB"] Parameters [] Preparation ["No fasting required", "Complete mandatory genetic counselling session", "Inform phlebotomist of all medications and supplements"] Indications ["Suspected Baraitser-Winter syndrome type 1", "Need for definitive molecular diagnosis", "Genetic counselling for families with suspected cases"] Measurement technique Confirm with laboratory Codes LOINC: 96527-2 ICD-10: Q87.8 Clinical summary This genetic test identifies pathogenic variants within the ACTB gene, confirming a diagnosis of Baraitser-Winter syndrome type 1.
TEST-3052 ACTG1 Gene Baraitser‑Winter Syndrome Type 2 Genetic Test This test identifies pathogenic variants in the ACTG1 gene associated with Baraitser‑Winter syndrome type 2.	Whole Blood (Peripheral)	3–4 weeks (stat reporting available)	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the ACTG1 gene"] Parameters [] Preparation ["Provide detailed clinical history", "Provide a three-generation pedigree chart"] Indications ["Suspected Baraitser‑Winter syndrome type 2", "Family history of Baraitser‑Winter syndrome type 2"] Measurement technique Confirm with laboratory Codes LOINC: 95075-6 ICD-10: Q87.0 Clinical summary This test identifies pathogenic variants in the ACTG1 gene associated with Baraitser‑Winter syndrome type 2.
TEST-3316 ACTN1 Gene Bleeding Disorder, Platelet-Type 15 Genetic Test This genetic test evaluates the ACTN1 gene for pathogenic variants associated with Platelet-Type 15 Bleeding Disorder.	Peripheral Whole Blood	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the ACTN1 gene", "Single-nucleotide variants", "Insertions", "Deletions", "Copy number alterations"] Parameters [] Preparation ["No fasting required", "Provide detailed clinical history documenting bleeding symptoms", "Provide a three-generation family pedigree chart", "Provide any prior platelet function test results"] Indications ["Suspected inherited platelet function defect", "Family history of Platelet-Type 15 Bleeding Disorder", "Evaluation of unexplained bleeding"] Measurement technique Confirm with laboratory Codes LOINC: 78041-7 ICD-10: D69.1 Clinical summary This genetic test evaluates the ACTN1 gene for pathogenic variants associated with Platelet-Type 15 Bleeding Disorder.
TEST-4588 ADA Gene Severe Combined Immunodeficiency (ADA-SCID) Genetic Test This test identifies genetic mutations in the ADA gene responsible for Severe Combined Immunodeficiency (ADA-SCID). It uses Next-Generation Sequencing (NGS) for comprehensive analy...	Whole Blood (Peripheral)	3-4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the ADA gene", "Single-nucleotide resolution"] Parameters [] Preparation ["Pre-test genetic counseling required", "No specific fasting or medication adjustments needed"] Indications ["Suspected ADA-SCID", "Confirmation of positive newborn screening", "Evaluation of severe immunodeficiency"] Measurement technique Confirm with laboratory Codes LOINC: 21613-5 ICD-10: D81.3 Clinical summary This test identifies genetic mutations in the ADA gene responsible for Severe Combined Immunodeficiency (ADA-SCID). It uses Next-Generation Sequencing (NGS) for comprehensive analysis.
TEST-3975 ADA2 Gene Sequencing for Childhood-Onset Polyarteritis Nodosa Test This test evaluates the entire coding region of the ADA2 gene for mutations associated with DADA2.	Whole Blood (Venipuncture)	3 to 4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["ADA2 gene mutations", "Adenosine deaminase 2 deficiency"] Parameters [] Preparation ["Inform the phlebotomist about current medications.", "Inform the phlebotomist of any bleeding disorder or anticoagulant use."] Indications ["Suspected DADA2", "Childhood-onset polyarteritis nodosa", "Recurrent unexplained fevers", "Family history of DADA2"] Measurement technique Confirm with laboratory Codes LOINC: 95034-2 ICD-10: M30.0 Clinical summary This test evaluates the entire coding region of the ADA2 gene for mutations associated with DADA2.
TEST-5317 ADAM22 Gene Neurodevelopmental Disorder Genetic Test This test detects pathogenic variants in the ADAM22 gene associated with severe neurodevelopmental disorders and early-onset epileptic encephalopathy.	Peripheral Whole Blood (5-10 mL) or Saliva (Oragene DNA Kit)	3-4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["ADAM22 gene pathogenic variants (SNVs, indels, CNVs)", "Synaptic function related to ADAM22 protein"] Parameters [] Preparation ["No specific fasting required", "Continue prescribed medications unless advised otherwise by physician"] Indications ["Diagnosis of suspected ADAM22-related disorders", "Evaluation of early-onset epileptic encephalopathy", "Assessment of severe intellectual disability and autism spectrum traits"] Measurement technique Confirm with laboratory Codes LOINC: 101246-3 ICD-10: G40.89, F70-F79, F84.0 Clinical summary This test detects pathogenic variants in the ADAM22 gene associated with severe neurodevelopmental disorders and early-onset epileptic encephalopathy.

Category overview

Genetic: overview

Unlocking the blueprint of your DNA provides profound, proactive insights into your family’s future and personal health risks. Integrated within our advanced Biochemistry and molecular services, specialized Genetic testing evaluates inherited traits, metabolic predispositions, and carrier statuses. Utilizing cutting-edge diagnostic technology, comprehensive genetic screening offers the vital clarity needed to safely guide tailored medical strategies and family planning. As an undisputed leader in innovation among diagnostic labs in Dubai and the UAE, DNA Labs guarantees the highest standards of strict patient confidentiality, unparalleled diagnostic precision, and rapid reporting. Empower your health decisions with certainty—book your genetic testing in UAE, coordinate a secure sample collection, or connect with our specialized genetics team today.

Before booking

Use the test details as a conversation starter

The right diagnostic option depends on your reason for testing and individual circumstances. Check the listed specimen and timing, then confirm any preparation requirements with the ordering clinician or laboratory before collection.